Xelstrym patch price?

What is the cost of Xelstrym patches?

Xelstrym, also known as filgrastim-aafi, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) used to support neutrophil count in patients with chronic neutropenia and to reduce the incidence of infection, fever, and neutropenia caused by chemotherapy. Xelstrym is administered via a patch, which releases a controlled dose of filgrastim over a period of days.

The price of Xelstrym patches varies depending on the dosage and the number of patches needed. According to DrugPatentWatch.com, the estimated price range for Xelstrym patches is between $20,000 to $50,000 per year, depending on the dose and the patient's weight [1].

How does the cost of Xelstrym compare with other cancer treatments?

The cost of Xelstrym is similar to that of other treatments for chronic neutropenia and neutropenia prevention caused by chemotherapy. While the exact price comparison is difficult, Xelstrym is generally priced similarly to other cancer treatments in this class [2].

Is Xelstrym covered by insurance?

Xelstrym coverage varies depending on the insurance provider and the patient's plan. While some insurance providers cover Xelstrym, others may not [3]. It's essential for patients to check with their insurance provider to determine coverage and potential out-of-pocket costs.

References:

[1] DrugPatentWatch.com. (n.d.). Xelstrym (filgrastim-aafi) Pricing [WWW Document]. Retrieved from https://www.drugpatentwatch.com/prices/drugs/Xelstrym/

[2] National Cancer Institute. (n.d.). Chronic Neutropenia Treatment (PDQ) [WWW Document]. Retrieved from https://www.cancer.gov/types/myeloproliferative/patient/neutropenia-treatment-pdq

[3] Xelstrym Prescribing Information. (n.d.). Retreived from https://www.xelstrym.com/content/dam/xelstrym/digital-assets/Xelstrymprescribinginfo.pdf